New patent expiration for Mylan Speciality drug ELESTRIN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ELESTRIN
Annual Drug Patent Expirations for ELESTRIN

Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

ELESTRIN drug price trends.

Drug patent litigation for ELESTRIN.

This drug has fifty-two patent family members in twenty countries.

The generic ingredient in ELESTRIN is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top